Target intelligence / Profile preview

Novel transcript, antisense to MARVELD3 (ENSG00000260593)

Target
ENSG00000260593
Molecular classification
Other, Noncoding RNA, antisense transcript
01

Overview

This entry refers to a noncoding RNA transcript antisense to MARVELD3 (ENSG00000260593). The transcript does not encode a protein and is classified as a noncoding variant located near the MARVELD3 locus. Its function is undetermined, but antisense transcripts can sometimes regulate expression of their sense counterparts through RNA interference or other mechanisms. MARVELD3 itself encodes a tight junction-associated transmembrane protein with roles in epithelial barrier function, cell migration, and cancer biology[1][2][4][5]. No therapeutic drugs, biomarkers, or significant molecular mediators are documented for this antisense transcript. No molecular family (e.g., receptor, ion channel, transporter, enzyme) is assigned to this locus. Key Point: ENSG00000260593 is an antisense, noncoding transcript—not a canonical drug target or receptor. The drug target MARVELD3 is a distinct protein-coding gene associated with epithelial tight junctions, with possible roles in cancer biology. If you seek information about the protein target MARVELD3 itself, you should focus searches on that gene, not its antisense transcript[3][5].

02

Biological functions

Unknown; potentially regulatory, affecting MARVELD3 expressionMARVELD3 protein is involved in tight junction assembly and paracellular ion conductivity
03

Disease associations

Unknown for antisense transcriptMARVELD3 protein is associated as a prognostic biomarker in oral squamous cell carcinoma and is involved in cell migration, epithelial remodeling, and possibly cancer progression

Beyond the preview

Go deeper on Novel transcript, antisense to MARVELD3 (ENSG00000260593).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to MARVELD3 (ENSG00000260593).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call